These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38490918)

  • 21. Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Gentle SJ; Rysavy MA; Li L; Laughon MM; Patel RM; Jensen EA; Hintz S; Ambalavanan N; Carlo WA; Watterberg K;
    JAMA Netw Open; 2023 May; 6(5):e2315315. PubMed ID: 37256621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchopulmonary dysplasia precursors influence risk of white matter injury and adverse neurodevelopmental outcome in preterm infants.
    Grelli KN; Keller RL; Rogers EE; Partridge JC; Xu D; Barkovich AJ; Gano D
    Pediatr Res; 2021 Aug; 90(2):359-365. PubMed ID: 32937647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severity of Bronchopulmonary Dysplasia Among Very Preterm Infants in the United States.
    Jensen EA; Edwards EM; Greenberg LT; Soll RF; Ehret DEY; Horbar JD
    Pediatrics; 2021 Jul; 148(1):. PubMed ID: 34078747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants.
    Subramaniam P; Ho JJ; Davis PG
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001243. PubMed ID: 34661278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Jensen EA; Wiener LE; Rysavy MA; Dysart KC; Gantz MG; Eichenwald EC; Greenberg RG; Harmon HM; Laughon MM; Watterberg KL; Walsh MC; Yoder BA; Lorch SA; DeMauro SB;
    JAMA Netw Open; 2023 May; 6(5):e2312277. PubMed ID: 37155165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Patent Ductus Arteriosus Ligation With Death or Neurodevelopmental Impairment Among Extremely Preterm Infants.
    Weisz DE; Mirea L; Rosenberg E; Jang M; Ly L; Church PT; Kelly E; Kim SJ; Jain A; McNamara PJ; Shah PS
    JAMA Pediatr; 2017 May; 171(5):443-449. PubMed ID: 28264088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.
    Chen X; Li H; Qiu X; Yang C; Walther FJ
    BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurodevelopmental and Behavioral Outcomes in Extremely Premature Neonates With Ventriculomegaly in the Absence of Periventricular-Intraventricular Hemorrhage.
    Pappas A; Adams-Chapman I; Shankaran S; McDonald SA; Stoll BJ; Laptook AR; Carlo WA; Van Meurs KP; Hintz SR; Carlson MD; Brumbaugh JE; Walsh MC; Wyckoff MH; Das A; Higgins RD;
    JAMA Pediatr; 2018 Jan; 172(1):32-42. PubMed ID: 29181530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
    Kirpalani H; Ratcliffe SJ; Keszler M; Davis PG; Foglia EE; Te Pas A; Fernando M; Chaudhary A; Localio R; van Kaam AH; Onland W; Owen LS; Schmölzer GM; Katheria A; Hummler H; Lista G; Abbasi S; Klotz D; Simma B; Nadkarni V; Poulain FR; Donn SM; Kim HS; Park WS; Cadet C; Kong JY; Smith A; Guillen U; Liley HG; Hopper AO; Tamura M;
    JAMA; 2019 Mar; 321(12):1165-1175. PubMed ID: 30912836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships of Severity of Bronchopulmonary Dysplasia with Adverse Neurodevelopmental Outcomes and Poor Respiratory Function at 7-8 Years of Age.
    Doyle LW; Ranganathan S; Mainzer RM; Cheong JLY;
    J Pediatr; 2024 Jun; 269():114005. PubMed ID: 38453001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-year neurodevelopmental outcome in children born extremely preterm: the EPI-DAF study.
    van Beek PE; Rijken M; Broeders L; Ter Horst HJ; Koopman-Esseboom C; de Kort E; Laarman C; Mulder-de Tollenaer SM; Steiner K; Swarte RM; van Westering-Kroon E; Oei SG; Leemhuis AG; Andriessen P;
    Arch Dis Child Fetal Neonatal Ed; 2022 Sep; 107(5):467-474. PubMed ID: 35236745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the patterns of respiratory support and incidence of bronchopulmonary dysplasia; a single center experience.
    Algarni SS; Ali K; Alsaif S; Aljuaid N; Alzahrani R; Albassam M; Alanazi R; Alqueflie D; Almutairi M; Alfrijan H; Alanazi A; Ghazwani A; Alshareedah S; Alotaibi TF; Alqahtani MM; Aljohani H; Ismaeil TT; Alwadeai KS; Siraj RA; Alsaif A; Asiri S; Halabi S; Alanazi AMM
    BMC Pediatr; 2023 Jul; 23(1):357. PubMed ID: 37442954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital and Neurodevelopmental Outcomes in Nano-Preterm Infants Receiving Invasive vs Noninvasive Ventilation at Birth.
    Shukla VV; Souder JP; Imbrock G; Hu M; Rahman AKMF; Travers CP; Ambalavanan N; Carlo WA; Lal CV
    JAMA Netw Open; 2022 Aug; 5(8):e2229105. PubMed ID: 36036932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurodevelopmental outcomes of premature infants with bronchopulmonary dysplasia.
    Gallini F; Arena R; Stella G; Frezza S; Maggio L
    Acta Biomed; 2014 Jun; 85(1):30-4. PubMed ID: 24957344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasal high flow therapy for primary respiratory support in preterm infants.
    Hodgson KA; Wilkinson D; De Paoli AG; Manley BJ
    Cochrane Database Syst Rev; 2023 May; 5(5):CD006405. PubMed ID: 37144837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventilation and respiratory outcome in extremely preterm infants: trends in the new millennium.
    Regin Y; Gie A; Eerdekens A; Toelen J; Debeer A
    Eur J Pediatr; 2022 May; 181(5):1899-1907. PubMed ID: 35034202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definitions of bronchopulmonary dysplasia and long-term outcomes of extremely preterm infants in Korean Neonatal Network.
    Jeon GW; Oh M; Chang YS
    Sci Rep; 2021 Dec; 11(1):24349. PubMed ID: 34934085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.